Clinical Trial

Relationship of DV Doppler Parameters to Perinatal Outcomes in IUGR vs Non-IUGR

Study acronym: DV-FGR
Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated October 2, 2025 (before its estimated November 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
This observational study investigates whether blood flow in the ductus venosus, a small fetal vein measured by Doppler ultrasound, is related to pregnancy outcomes. A total of pregnant women with and without intrauterine growth restriction (IUGR) will be examined between 24 and 37 weeks of gestation. Ductus venosus Doppler parameters will be recorded and compared with perinatal outcomes such as Apgar scores, neonatal intensive care unit admission, and perinatal mortality. The aim of this research is to improve the early identification of high-risk pregnancies and to support better monitoring and management strategies for fetal health.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-09-17; most recent amendment 2025-09-30.
Trial Details
NCT Number NCT07190157
Lead Sponsor Izmir City Hospital
Conditions Fetal Growth Restriction, Perinatal Outcome, Pregnancy, High Risk
Enrollment 160 participants
Start Date 2025-10-01
Primary Completion 2025-11-30 (estimated)
Study Completion 2025-11-30 (estimated)
Updated on ClinicalTrials.gov 2025-10-02